Onconova Therapeutics Inc


Market Cap$78.43M

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Onconova Therapeutics IncOnconova Therapeutics Inc00%---

Current Fair Value

13.8% downside

Overvalued by 13.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$78.43 Million
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares21,003,409
Avg 30 Day Volume165,066


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Onconova Therapeutics Inc

CEO: Steven Fruchtman